Brentan (miconazole)
PreclinicalSmall molecule
Brentan (miconazole) is one of 4 small molecule programs targeting Estrogen. It is currently in Preclinical.
1
Indications
1
Total Trials
0
Active Trials
3
Competitors
Pipeline
Status by Indication[3][1]
Competition
Competitive Landscape
3 competitors in Estrogen
#DrugCompanyPhaseTrials
1Ganirelix Acetate
OOrganon and Co
Approved
Bazedoxifene
PfizerPhase 2
Estrasorb
Novo NordiskPreclinical
Brentan (miconazole)
UUniversity of Southern Denmark
Preclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Trials by Indication[1]
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for Brentan (miconazole). EMBL-EBI & Wellcome Sanger Institute.
- [4]
Details
Drug Info
Quick Facts
- Modality
- Small molecule[2]
- Highest Phase
- Preclinical[1]
- Company
- UUniversity of Southern Denmark